Top

Published in:

01-01-2021 | Acute Respiratory Distress-Syndrome | COVID-19 in Intensive Care

What’s new in ECMO for COVID-19?

Authors: Graeme MacLaren, Alain Combes, Daniel Brodie

Published in: Intensive Care Medicine | Issue 1/2021

Excerpt

The first studies of coronavirus disease 2019 (COVID-19) from China reported high mortality rates in patients supported with extracorporeal membrane oxygenation (ECMO) [1]. Very little was known about the natural history of the virus, prompting both speculation about the precise role of ECMO [2] and recommendations for its use [3, 4]. Many clinicians were concerned about using high-cost, resource-intensive therapies for a small, select proportion of critically ill patients if national healthcare systems were in danger of being overwhelmed. It was unclear whether the reasons underlying these initial, apparently high mortality rates related to the pathophysiology of the virus itself or the use of ECMO by overburdened clinicians in suboptimal circumstances. Data has recently emerged outlining the potential role of ECMO for COVID-19 with greater clarity. …

Henry BM, Lippi G (2020) Poor survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): pooled analysis of early reports. J Crit Care 58:27–28CrossRef

MacLaren G, Fisher D, Brodie D (2020) Preparing for the most critically ill patients with COVID-19: the potential role of extracorporeal membrane oxygenation. JAMA 323:1245–1246CrossRef

Bartlett RH, Ogino MT, Brodie D et al (2020) Initial ELSO guidance document: ECMO for COVID-19 patients with severe cardiopulmonary failure. ASAIO J 66:472–474CrossRef

Alhazzani W, Moller MH, Arabi YM et al (2020) Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Intensive Care Med 46:854–887CrossRef

Schmidt M, Hajage D, Lebreton G et al (2020) Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study. Lancet Respir Med S2213–2600(20):30328–3. https://doi.org/10.1016/S2213-2600(20)30328-3CrossRef

Combes A, Hajage D, Capellier G et al (2018) Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med 378:1965–1975CrossRef

Ferguson ND, Pham T, Gong MN (2020) How severe COVID-19 infection is changing ARDS management. Intensive Care Med. https://doi.org/10.1007/s00134-020-06245-6CrossRefPubMedPubMedCentral

Helms J, Tacquard C, Severac F et al (2020) High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med 46:1089–1098CrossRef

Barbaro R, MacLaren G, Boonstra P et al (2020) Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization. Lancet. 396(10257):1071–1078. https://doi.org/10.1016/S0140-6736(20)32008-0CrossRefPubMedPubMedCentral

10.

Guervilly C, Prud’homme E, Pauly V et al (2019) Prone positioning and extracorporeal membrane oxygenation for severe acute respiratory distress syndrome: time for a randomized trial? Intensive Care Med 45:1040–1042CrossRef

11.

Giani M, Martucci G, Madotto F et al (2020) Prone positioning during venovenous extracorporeal membrane oxygenation in acute respiratory distress syndrome: a multicenter cohort study and propensity-matched analysis. Ann Am Thorac Soc. https://doi.org/10.1513/AnnalsATS.202006-625OCCrossRefPubMed

12.

Mustafa AK, Alexander P, Joshi DJ et al (2020) Extracorporeal membrane oxygenation for patients with COVID-19 in severe respiratory failure. JAMA Surg e203950. https://doi.org/10.1001/jamasurg.2020.3950

13.

Marini JJ, Dellinger RP, Brodie D (2020) Integrating the evidence: confronting the COVID-19 elephant. Intensive Care Med 46:1904–1907. https://doi.org/10.1007/s00134-020-06195-zCrossRefPubMed

14.

Worku E, Gill D, Brodie D et al (2020) Provision of ECPR during COVID-19: evidence, equity, and ethical dilemmas. Crit Care 24:462CrossRef

15.

Belhadjer Z, Meot M, Bajolle F et al (2020) Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic. Circulation. https://doi.org/10.1161/CIRCULATIONAHA.120.048360CrossRefPubMedPubMedCentral

Title: What’s new in ECMO for COVID-19?
Authors: Graeme MacLaren
Alain Combes
Daniel Brodie
Publication date: 01-01-2021
Publisher: Springer Berlin Heidelberg
Keywords: Acute Respiratory Distress-Syndrome
COVID-19
ECMO
ECMO
Published in: Intensive Care Medicine / Issue 1/2021
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-020-06284-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

What’s new in ECMO for COVID-19?

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2021

Neuroanatomical substrates of generalized brain dysfunction in COVID-19

Clinical validation of precision medicine protocols: the last mile is the longest

COVID-19: what the clinician should know about post-mortem findings

Prediction model for intracranial hypertension demonstrates robust performance during external validation on the CENTER-TBI dataset

Neurofilament to predict post-anoxic neurological outcome: are we ready for the prime time?

Efficacy and safety of tranexamic acid in acute traumatic brain injury: a systematic review and meta-analysis of randomized-controlled trials